Skip to main content
logo
Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
320.71
-2.02 (-0.63%)
At close: Sep 18, 2026, 4:00 PM EDT
322.50
+1.79 (0.56%)
Pre-market: Sep 21, 2026, 5:50 AM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Diagnostics (Dx) Revenue
11.16B10.88B10.14B
Biopharma Laboratory Services (BLS) Revenue
3.21B3.10B2.92B
Revenue (Other)
-21.80M-23.00M-58.00M
Revenue (Total)
14.35B13.95B13.01B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Diagnostics (Dx) Operating Earnings
1.85B1.78B1.61B
Biopharma Laboratory Services (BLS) Operating Earnings
531.20M498.50M458.90M
Operating Income (Other)
-885.50M-893.70M-978.50M
Operating Income (Total)
1.50B1.38B1.09B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
North America % Total Revenue
87.00%87.00%
Europe % Total Revenue
9.00%9.00%
Other Geography % Total Revenue
4.00%4.00%
Organic Revenue Growth
4.40%3.90%